Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Adapalene wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Topical use. Adapalene 0.1% (OTC) or 0.3% (prescription) gel/cream is applied as a thin layer to the whole affected area once daily, usually at night, starting every other day and building to nightly as tolerated. Full benefit takes ~8-12 weeks. There is no oral or systemic dose — it is not ingested. It is most effective combined with benzoyl peroxide. This library does not provide an ingestion protocol.
evening
Adapalene 0.1% gel/cream (OTC), applied nightly to the whole area
Topical use, typically ~2-5% tranexamic acid in a serum applied to areas of melasma once or twice daily, alongside daily sunscreen. There is no oral or systemic dose in this cosmetic context — the ingested medication is a separate prescription use with clotting-risk considerations. This library does not provide an ingestion protocol.
any
Leave-on topical serum (≈2-5% tranexamic acid)
Throughout
8-12 weeks
Throughout
First weeks
Throughout
8-12 weeks
Throughout
Throughout
A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
Br J Dermatol (1998) · Meta analysis · n=900
Meta-analysis of five randomized investigator-blind trials (900 patients) in mild-to-moderate acne
Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
J Am Acad Dermatol (2007) · Rct · n=517
Pivotal 12-week double-blind RCT (n=517) of adapalene-BPO vs adapalene, BPO, or vehicle
Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis.
Br J Dermatol (2021) · Systematic review
Systematic review and network meta-analysis of 40 trials (18,089 participants) of topical acne treatments
Topical tranexamic acid as a promising treatment for melasma.
J Res Med Sci (2014) · Rct · n=50
Double-blind 12-week split-face RCT in 50 women: 3% topical TXA on one side vs 3% hydroquinone + 0.01% dexamethasone on the other, twice daily
The effectiveness and safety of 3% tranexamic acid cream vs. 4% hydroquinone cream for mixed-type melasma in skin of color: a double-blind, split-face, randomized controlled trial.
Acta Dermatovenerol Alp Pannonica Adriat (2024) · Rct · n=20
Double-blind 8-week split-face RCT in 20 skin-of-color subjects comparing 3% topical TXA cream vs 4% hydroquinone cream
Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials.
J Dermatolog Treat (2024) · Meta analysis
Meta-analysis of 22 RCTs (1280 patients) of TXA delivered orally, topically, or by injection for melasma
Adapalene has a higher evidence score (9/10 vs 6/10) and wins in 2 of 3 categories.
No known interactions between Adapalene and Tranexamic Acid (topical) have been documented in our database. However, always consult a healthcare provider before combining supplements.